Vaccine dosage and route* | Strain composition |
---|---|
Year 1: | Northern Hemisphere 2003–2004 formulation: |
3 μg ID or | A/New Caledonia/20/99 (H1N1) (A/New Caledonia/20/99-like strain) |
6 μg ID or | A/Panama/2007/99 (H3N2) (A/Moscow/10/99-like strain) |
15 μg IM | B/Shandong/7/97 (B/Hong Kong/330/2001-like strain) |
Year 2: | Northern Hemisphere 2004–2005 formulation: |
9 μg ID or | A/New Caledonia/20/99 (H1N1) (A/New Caledonia/20/99-like strain) |
15 μg IM | A/Wyoming/3/2003 (H3N2) (A/Fujian/411/2002-like strain) B/Jiangsu/10/2003 (B/Shanghai/361/2002-like strain) |
Year 3: | Southern Hemisphere 2005 formulation: |
9 μg ID, or | A/New Caledonia/20/99 IVR-116 (H1N1) (A/New Caledonia/20/99-like strain) |
15 μg IM | A/Wellington/1/2004 IVR-139 (H3N2) (A/Wellington/1/2004-like strain) B/Jiangsu/10/2003 (B/Shanghai/361/2002-like strain) |